vs
Archrock, Inc.（AROC）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Archrock, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.8倍（$377.1M vs $207.3M），Archrock, Inc.净利率更高（31.0% vs -62.0%，领先93.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 15.5%），Archrock, Inc.自由现金流更多（$126.7M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 18.5%）
Archrock, Inc. 是领先的天然气压缩服务及相关设备解决方案供应商，主要服务北美油气领域，核心业务涵盖压缩系统租赁、维护、售后支持及销售，覆盖上游生产、中游运输与天然气加工板块。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AROC vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $377.1M | $207.3M |
| 净利润 | $116.8M | $-128.6M |
| 毛利率 | 53.0% | — |
| 营业利润率 | 39.4% | -54.7% |
| 净利率 | 31.0% | -62.0% |
| 营收同比 | 15.5% | 25.9% |
| 净利润同比 | 95.4% | 3.5% |
| 每股收益（稀释后） | $0.67 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $377.1M | $207.3M | ||
| Q3 25 | $382.4M | $159.9M | ||
| Q2 25 | $383.2M | $166.5M | ||
| Q1 25 | $347.2M | $139.3M | ||
| Q4 24 | $326.4M | $164.6M | ||
| Q3 24 | $292.2M | $139.5M | ||
| Q2 24 | $270.5M | $147.0M | ||
| Q1 24 | $268.5M | $108.8M |
| Q4 25 | $116.8M | $-128.6M | ||
| Q3 25 | $71.2M | $-180.4M | ||
| Q2 25 | $63.4M | $-115.0M | ||
| Q1 25 | $70.8M | $-151.1M | ||
| Q4 24 | $59.8M | $-133.2M | ||
| Q3 24 | $37.5M | $-133.5M | ||
| Q2 24 | $34.4M | $-131.6M | ||
| Q1 24 | $40.5M | $-170.7M |
| Q4 25 | 53.0% | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 47.4% | — | ||
| Q4 24 | 46.3% | — | ||
| Q3 24 | 44.4% | — | ||
| Q2 24 | 41.5% | — | ||
| Q1 24 | 42.1% | — |
| Q4 25 | 39.4% | -54.7% | ||
| Q3 25 | 25.3% | -106.9% | ||
| Q2 25 | 22.5% | -64.8% | ||
| Q1 25 | 26.5% | -102.6% | ||
| Q4 24 | 24.0% | -74.3% | ||
| Q3 24 | 18.1% | -94.6% | ||
| Q2 24 | 17.6% | -79.1% | ||
| Q1 24 | 20.0% | -151.9% |
| Q4 25 | 31.0% | -62.0% | ||
| Q3 25 | 18.6% | -112.8% | ||
| Q2 25 | 16.6% | -69.0% | ||
| Q1 25 | 20.4% | -108.5% | ||
| Q4 24 | 18.3% | -80.9% | ||
| Q3 24 | 12.8% | -95.7% | ||
| Q2 24 | 12.7% | -89.5% | ||
| Q1 24 | 15.1% | -156.8% |
| Q4 25 | $0.67 | $-1.28 | ||
| Q3 25 | $0.40 | $-1.81 | ||
| Q2 25 | $0.36 | $-1.17 | ||
| Q1 25 | $0.40 | $-1.57 | ||
| Q4 24 | $0.35 | $-1.34 | ||
| Q3 24 | $0.22 | $-1.40 | ||
| Q2 24 | $0.22 | $-1.52 | ||
| Q1 24 | $0.26 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $-80.0M |
| 总资产 | $4.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $1.6M | $421.0M | ||
| Q3 25 | $4.1M | $202.5M | ||
| Q2 25 | $5.9M | $176.3M | ||
| Q1 25 | $4.8M | $127.1M | ||
| Q4 24 | $4.4M | $174.0M | ||
| Q3 24 | $3.7M | $150.6M | ||
| Q2 24 | $919.0K | $480.7M | ||
| Q1 24 | $1.2M | $112.3M |
| Q4 25 | $1.5B | $-80.0M | ||
| Q3 25 | $1.4B | $9.2M | ||
| Q2 25 | $1.4B | $151.3M | ||
| Q1 25 | $1.3B | $144.2M | ||
| Q4 24 | $1.3B | $255.0M | ||
| Q3 24 | $1.3B | $346.8M | ||
| Q2 24 | $894.5M | $432.4M | ||
| Q1 24 | $882.1M | $140.3M |
| Q4 25 | $4.3B | $1.5B | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.4B | $1.3B | ||
| Q1 25 | $4.0B | $1.3B | ||
| Q4 24 | $3.8B | $1.5B | ||
| Q3 24 | $3.8B | $1.5B | ||
| Q2 24 | $2.7B | $1.6B | ||
| Q1 24 | $2.7B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $214.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $126.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | 33.6% | -48.6% |
| 资本支出强度资本支出/营收 | 23.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.84× | — |
| 过去12个月自由现金流最近4个季度 | $119.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $214.5M | $-99.8M | ||
| Q3 25 | $164.5M | $-91.4M | ||
| Q2 25 | $127.5M | $-108.3M | ||
| Q1 25 | $115.6M | $-166.5M | ||
| Q4 24 | $124.3M | $-79.3M | ||
| Q3 24 | $96.9M | $-67.0M | ||
| Q2 24 | $70.7M | $-77.0M | ||
| Q1 24 | $137.7M | $-190.7M |
| Q4 25 | $126.7M | $-100.8M | ||
| Q3 25 | $29.5M | $-92.7M | ||
| Q2 25 | $16.0M | $-110.7M | ||
| Q1 25 | $-52.5M | $-167.8M | ||
| Q4 24 | $26.4M | $-79.5M | ||
| Q3 24 | $26.9M | $-68.6M | ||
| Q2 24 | $-20.6M | $-79.0M | ||
| Q1 24 | $37.9M | $-193.9M |
| Q4 25 | 33.6% | -48.6% | ||
| Q3 25 | 7.7% | -58.0% | ||
| Q2 25 | 4.2% | -66.5% | ||
| Q1 25 | -15.1% | -120.5% | ||
| Q4 24 | 8.1% | -48.3% | ||
| Q3 24 | 9.2% | -49.2% | ||
| Q2 24 | -7.6% | -53.7% | ||
| Q1 24 | 14.1% | -178.2% |
| Q4 25 | 23.3% | 0.5% | ||
| Q3 25 | 35.3% | 0.8% | ||
| Q2 25 | 29.1% | 1.5% | ||
| Q1 25 | 48.4% | 1.0% | ||
| Q4 24 | 30.0% | 0.1% | ||
| Q3 24 | 24.0% | 1.2% | ||
| Q2 24 | 33.7% | 1.4% | ||
| Q1 24 | 37.2% | 3.0% |
| Q4 25 | 1.84× | — | ||
| Q3 25 | 2.31× | — | ||
| Q2 25 | 2.01× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.58× | — | ||
| Q2 24 | 2.05× | — | ||
| Q1 24 | 3.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AROC
| Horsepower Group Three | $112.6M | 30% |
| Horsepower Group Two | $108.5M | 29% |
| Horsepower Group One | $105.9M | 28% |
| Services | $32.9M | 9% |
| Over Counter Parts And Component Sales | $17.0M | 5% |
| Transferred At Point In Time | $1.4M | 0% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
